OFI Invest Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

OFI Invest Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.54M	Sell	10,449 -58,784	-85%	-$26.1M	0.05%	182
2026 Q1	$26.8M	Buy	69,233 +109	+0.2%	+$50.8K	0.35%	75
2025 Q4	$26.7M	Buy	69,124 +68,832	+23,573%	+$29.7M	0.38%	68
2025 Q3	$97.3K	Buy	292 +78	+36%	+$32.6K	﹤0.01%	279
2025 Q2	$81.2K	Sell	214 -6,381	-97%	-$2.94M	﹤0.01%	291
2025 Q1	$2.96M	Buy	6,595 +399	+6%	+$186K	0.08%	119
2024 Q4	$2.41M	Buy	+6,196	New	+$2.87M	0.06%	140
2024 Q2	$35K	Buy	80 +6	+8%	+$2.6K	﹤0.01%	292
2024 Q1	$28.6K	Sell	74 -1	-1%	-$423	﹤0.01%	263
2023 Q4	$27.6K	Sell	75 -2	-3%	-$739	﹤0.01%	218
2023 Q3	$25.3K	Buy	+77	New	+$26.9K	﹤0.01%	195
2023 Q2	–	Sell	-185,576	Closed	-$589K	–	147
2023 Q1	$589K	Buy	+185,576	New	+$55.7M	﹤0.01%	129

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

OFI Invest Asset Management's VRTX Position: Q2 2026 in Review

OFI Invest Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 85% in Q2 2026, selling an estimated $26.1M and leaving 10,449 shares worth $4.54M. The position accounts for 0.05% of the portfolio, ranked #182.

OFI Invest Asset Management first reported a position in VRTX in Q1 2023 and has held it in 12 quarters since. The position peaked at $26.8M in Q1 2026. 1,091 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

OFI Invest Asset Management held 10,449 shares of Vertex Pharmaceuticals worth $4.54M as of Q2 2026.
OFI Invest Asset Management sold 58,784 Vertex Pharmaceuticals shares in Q2 2026, an estimated $26.1M.
Vertex Pharmaceuticals made up 0.05% of OFI Invest Asset Management's portfolio in Q2 2026, its #182 holding.
OFI Invest Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 12 quarters since.
OFI Invest Asset Management's Vertex Pharmaceuticals position peaked at $26.8M in Q1 2026.
1,091 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.